Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a multi-modal image database that aims to boost ...

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an ...

The funds will go towards scaling C2N Diagnostics’ laboratory services and advancing the company’s range of diagnostic tests.

A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

The National Institute for Cancer Research and Treatment (NICRAT) in partnership with a Roche, multinational healthcare ...

Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

Swiss pharma giant, Roche, in collaboration with Oncopadi Technologies, has launched a Breast Cancer Access Navigation and Testing Programme ...

The Diagnostic Specialty Enzymes Market was valued at US$ 1.0 billion in 2022 and is projected to grow at a CAGR of 6.9% from ...

The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...

Newsweek is partnering with Plant-A Insights Group to recognize America's Most Loved Brands 2025. These brands not only ...